Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Molecular Profiling Study of EGFR-Mutated NSCLC Patients Treated With 1L Osimertinib Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: Initial Results From CHRYSALIS-2 Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dose-Finding Phase 1B Study of Subcutaneous Atezolizumab in Advanced NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Results of Osimertinib Plus Platinum-Pemetrexed in Newly Diagnosed EGFR Mutation-Positive NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Managing IRRs During Amivantamab Treatment in the CHRYSALIS Study May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) AEGEAN Trial: Durvalumab Combined With Chemotherapy for Resectable NSCLC May 02, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Combination Therapy with Pembrolizumab and Etoposide/Platinum for Small Cell Lung Cancer Apr 20, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) New Treatment for Extensive-Stage SCLC: Atezolizumab in MAURIS Trial Apr 20, 2023
